Huawei announces Sense G1, its first continuous glucose monitoring device

Aadil Raval
2 Min Read
Highlights
  • Huawei has announced the next-gen smart continuous glucose monitoring device.
  • With an Apple AirTag-like device, the smart CGM brings glucose monitoring 24/7 and with integration to your Huawei phones and smartwatches.
  • Huawei Sense G1 is expected to arrive soon although the pricing and availability is not confirmed yet.

Huawei has officially announced the upcoming Huawei Sense G1, its first-ever continuous glucose monitoring (CGM) device. It is said to be launch-ready and will feature an Apple AirTag-like design, tracking glucose levels 24/7.

Huawei Sense G1 brings glucose monitoring to your phone

The Weibo teaser and reports on Sense G1 discuss the design and application of these CGM sensors. With an AirTag-like design, this CGM device connects directly to your body, sensing blood glucose throughout the day and night. The tiny, soft needles pierce through the skin, collecting readings from the fluids in your body using glucose oxidase and electrodes, which are then converted into blood sugar readings.

Huawei wants to market the device as ‘smart’ and ‘professional,’ and thus, the marketing that follows. The soon-to-be-launched Sense G1 will connect with your smartphone or Huawei smartwatches, sending readings with an average delay of 5 to 15 minutes. This means the recorded readings will be reflected on the companion app after the aforementioned delay. 

Huawei Sense G1 Glucose monitoring
Image Credits: Huawei Weibo

With a mean absolute relative difference (MARD) below 10%, the Huawei Sense G1 will be able to reference measurements with greater accuracy and less deviation from laboratory testing.

The Chinese smartphone maker wants to position itself as a leading manufacturer of CGM  (and probably other healthcare products) using smart interaction within the Huawei and HarmonyOS ecosystem and cutting-edge designs. The Sense G1 has already received Class III certification from China’s National Medical Products Administration, which is the highest medical device risk category in the country, sharing space with artificial joints and cardiac stents. 

Neither the pricing nor the availability has been confirmed so far. It has been under testing for quite a while. In fact, the CTO of Huawei Terminal BG, Li Xiaolong, wore the Sense G1 CGM for a period of 35 months. It gives us hope that the Huawei CGM device will be out soon.

Keep up with the tech that actually matters.

From breaking news to deep dives, TrueTech brings you the tech stories worth knowing.
Add us as a preferred source on Google Search for quicker access to our coverage.

Add TrueTech as a preferred source on Google
Share This Article
Follow:
A wordsmith, a kin tech observer, a sci-fi fanatic and a scientific documentary buff.
Highlights
  • Huawei has announced the next-gen smart continuous glucose monitoring device.
  • With an Apple AirTag-like device, the smart CGM brings glucose monitoring 24/7 and with integration to your Huawei phones and smartwatches.
  • Huawei Sense G1 is expected to arrive soon although the pricing and availability is not confirmed yet.

Huawei has officially announced the upcoming Huawei Sense G1, its first-ever continuous glucose monitoring (CGM) device. It is said to be launch-ready and will feature an Apple AirTag-like design, tracking glucose levels 24/7.

Huawei Sense G1 brings glucose monitoring to your phone

The Weibo teaser and reports on Sense G1 discuss the design and application of these CGM sensors. With an AirTag-like design, this CGM device connects directly to your body, sensing blood glucose throughout the day and night. The tiny, soft needles pierce through the skin, collecting readings from the fluids in your body using glucose oxidase and electrodes, which are then converted into blood sugar readings.

Huawei wants to market the device as ‘smart’ and ‘professional,’ and thus, the marketing that follows. The soon-to-be-launched Sense G1 will connect with your smartphone or Huawei smartwatches, sending readings with an average delay of 5 to 15 minutes. This means the recorded readings will be reflected on the companion app after the aforementioned delay. 

Huawei Sense G1 Glucose monitoring
Image Credits: Huawei Weibo

With a mean absolute relative difference (MARD) below 10%, the Huawei Sense G1 will be able to reference measurements with greater accuracy and less deviation from laboratory testing.

The Chinese smartphone maker wants to position itself as a leading manufacturer of CGM  (and probably other healthcare products) using smart interaction within the Huawei and HarmonyOS ecosystem and cutting-edge designs. The Sense G1 has already received Class III certification from China’s National Medical Products Administration, which is the highest medical device risk category in the country, sharing space with artificial joints and cardiac stents. 

Neither the pricing nor the availability has been confirmed so far. It has been under testing for quite a while. In fact, the CTO of Huawei Terminal BG, Li Xiaolong, wore the Sense G1 CGM for a period of 35 months. It gives us hope that the Huawei CGM device will be out soon.

Keep up with the tech that actually matters.

From breaking news to deep dives, TrueTech brings you the tech stories worth knowing.
Add us as a preferred source on Google Search for quicker access to our coverage.

Add TrueTech as a preferred source on Google
Share This Article
Follow:
A wordsmith, a kin tech observer, a sci-fi fanatic and a scientific documentary buff.